BRPI9610977A2 - agonistas receptores hematopoiéticos multi-funcionais - Google Patents

agonistas receptores hematopoiéticos multi-funcionais Download PDF

Info

Publication number
BRPI9610977A2
BRPI9610977A2 BRPI9610977A BRPI9610977A BRPI9610977A2 BR PI9610977 A2 BRPI9610977 A2 BR PI9610977A2 BR PI9610977 A BRPI9610977 A BR PI9610977A BR PI9610977 A BRPI9610977 A BR PI9610977A BR PI9610977 A2 BRPI9610977 A2 BR PI9610977A2
Authority
BR
Brazil
Prior art keywords
xaa
arg
thr
leu
gly
Prior art date
Application number
BRPI9610977A
Other languages
English (en)
Portuguese (pt)
Inventor
Kure Klein Barbara
A Mcwherter Charles
M Baum Charles
P Mckearn John
G Giri Judith
L Zurfluh Linda
H Caparon Maire
L Summers Neema
R Staten Nicholas
c bauer S
C Lee Stephen
Feng Yiqing
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of BRPI9610977A2 publication Critical patent/BRPI9610977A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/524Thrombopoietin, i.e. C-MPL ligand
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5403IL-3
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI9610977A 1995-10-05 1996-10-04 agonistas receptores hematopoiéticos multi-funcionais BRPI9610977A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US483495P 1995-10-05 1995-10-05
PCT/US1996/015774 WO1997012985A2 (en) 1995-10-05 1996-10-04 Multi-functional hematopoietic receptor agonists

Publications (1)

Publication Number Publication Date
BRPI9610977A2 true BRPI9610977A2 (pt) 2019-09-17

Family

ID=21712756

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9610977A BRPI9610977A2 (pt) 1995-10-05 1996-10-04 agonistas receptores hematopoiéticos multi-funcionais

Country Status (14)

Country Link
EP (1) EP0854928A2 (cs)
JP (1) JPH11510062A (cs)
KR (1) KR100456212B1 (cs)
CN (2) CN1124348C (cs)
AU (1) AU705083B2 (cs)
BR (1) BRPI9610977A2 (cs)
CA (1) CA2234061A1 (cs)
CZ (1) CZ295518B6 (cs)
IL (1) IL123832A0 (cs)
MX (1) MX9802730A (cs)
NO (1) NO981500L (cs)
NZ (1) NZ320978A (cs)
PL (1) PL184424B1 (cs)
WO (1) WO1997012985A2 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US6660257B1 (en) 1996-10-25 2003-12-09 Pharmacia Corporation Circular permuteins of flt3 ligand
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US5969105A (en) * 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
US6242570B1 (en) 1997-07-10 2001-06-05 Beth Israel Deaconess Medical Center Production and use of recombinant protein multimers with increased biological activity
US6187564B1 (en) 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
US6165476A (en) * 1997-07-10 2000-12-26 Beth Israel Deaconess Medical Center Fusion proteins with an immunoglobulin hinge region linker
WO2001027621A2 (en) * 1999-10-07 2001-04-19 Pharmacia Corporation Competitive inhibition elisa for antibody detection
MXPA04000231A (es) 2001-07-11 2004-05-04 Maxygen Holdings Ltd Conjugados del factor de estimulacion de colonias de granulocitos.
RU2007149238A (ru) 2005-06-01 2009-07-20 Максиджен Холдингз Лтд. (Ky) Пегилированные полипептиды гксф и способы их получения
WO2007075899A2 (en) * 2005-12-21 2007-07-05 Maxygen, Inc. Dual agonist compounds and uses thereof
CN102675472B (zh) * 2012-05-07 2014-07-30 北京诺派生物科技有限公司 用于检测猪繁殖与呼吸综合症患猪的试剂盒
US9763984B2 (en) 2012-12-21 2017-09-19 Astellas Institute For Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
LT6161B (lt) 2013-09-27 2015-06-25 Uab Profarma Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Also Published As

Publication number Publication date
PL184424B1 (pl) 2002-10-31
CZ295518B6 (cs) 2005-08-17
NO981500L (no) 1998-05-20
CZ96598A3 (cs) 1998-09-16
NZ320978A (en) 2001-03-30
CN1204369A (zh) 1999-01-06
IL123832A0 (en) 1998-10-30
JPH11510062A (ja) 1999-09-07
MX9802730A (es) 1998-09-30
CN1590407A (zh) 2005-03-09
WO1997012985A3 (en) 1997-08-07
NO981500D0 (no) 1998-04-02
KR100456212B1 (ko) 2005-01-15
AU705083B2 (en) 1999-05-13
WO1997012985A2 (en) 1997-04-10
PL326072A1 (en) 1998-08-17
CA2234061A1 (en) 1997-04-10
CN1124348C (zh) 2003-10-15
AU7384496A (en) 1997-04-28
KR19990064068A (ko) 1999-07-26
EP0854928A2 (en) 1998-07-29

Similar Documents

Publication Publication Date Title
US12227581B2 (en) Anti-BCMA single domain antibodies and application thereof
BRPI9610977A2 (pt) agonistas receptores hematopoiéticos multi-funcionais
EA011876B1 (ru) АНТИТЕЛА К IFN-γ И СПОСОБ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ АНТИТЕЛ
CN110144326A (zh) 一种靶向性抗肿瘤t细胞及其制备方法和应用
EP2736924A1 (en) Antimicrobial peptide produced by intestinal lactobacillus salivarius
US6066318A (en) Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
AU725547B2 (en) Multi-functional chimeric hematopoietic receptor agonists
CN108840951A (zh) 一种由猪白蛋白、猪干扰素γ和猪干扰素α组成的融合蛋白及其制备方法
JP2001503265A (ja) 新規なflt3受容体アゴニスト
AU717733B2 (en) Novel G-CSF receptor agonists
US6358505B1 (en) G-CSF receptor agonists
KR101570453B1 (ko) 돼지 유행성 설사 바이러스의 재조합 스파이크 1 단백질을 발현하는 재조합 세포
US20230357325A1 (en) Composition and method to stabilize coronavirus spike glycoproteins in pre-fusion conformation
CN112592410B (zh) 犬腺病毒基因工程亚单位疫苗、其制备方法及应用
CN107245110A (zh) 一种由羊白蛋白、羊干扰素γ和羊干扰素τ组成的融合蛋白及其制备方法
MXPA99003877A (en) Multi-functional chimeric hematopoietic receptor agonists
CN108728464A (zh) 一种表达抗hiv双特异性抗体的微环dna载体及其制备方法和应用
JPH11239486A (ja) 組み換え型ヒト免疫不全ウイルス1型ウイルス、並びに、その産生に用いるウイルス分子クローン
JPH01110629A (ja) 感染防禦剤
Hairpin anesthetics, 2135 Genetic differences affecting the potency of stereoisomers of halothane
MXPA99003875A (en) NOVEL flt-3 RECEPTOR AGONISTS
NO179210B (no) Fremgangsmåte for fremstilling av et LIF polypeptid, rekombinant DNA molekyl som koder for LIF polypeptidet samt vertscelle for å uttrykke dette
JP2002515729A (ja) 新規g−csf受容体アゴニスト

Legal Events

Date Code Title Description
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2542 DE 24-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.